Carlo Visco has been associate professor of Hematology at the Department of Medicine, Section of Hematology, University of Verona, Verona, Italy, since 2019. Previously, he has been a consultant at the Department of Hematology and Cell Therapy, San Bortolo Hospital, Vicenza, Italy, between 2003 and 2019. He graduated in 1998 at the University of Verona, Italy, where he completed residency training in Hematology in 2002.

He has been post-doctoral research fellow at the Lymphoma and Myeloma Department at the University of Texas, MD Anderson Cancer Center, Houston, USA in 2000-2001. In 2010 he was honorable visiting physician at the Department of Pathology, University of Wisconsin School of Medicine, Madison, WI, USA, where he contributed to the formation of the International Diffuse large B-cell lymphoma Consortium Program Study, of whom he is an active and influential member. In 2013 he was awarded by the “Fondazione Calabresi” as young investigator publishing the best high impact clinical paper of 2013.

He is currently taking part to the conception, design and conduction of clinical trials, especially in mantle cell lymphoma and diffuse large B-cell lymphoma on a national and international basis. Prof Visco is an active member of the European society of hematology (EHA), of the European Mantle Cell Lymphoma Network (EMCLN) and of the Italian Lymphoma Foundation (FIL), where he is part of the presidential board. He is steadily involved in education and training as witnessed by his academic publications.